Specialist in hyaluronic acid for ophthalmology and rheumatology

Our group focuses primarily on therapeutic areas such as ophthalmology, rheumatology and neurology. We continuously develop our products thanks to clinical research and our privileged exchanges with the medical profession and patients. TRB's particular skills lie above all in the production, packaging and therapeutic challenges associated with hyaluronic acid. This expertise is reflected in our broad portfolio of products and related patents. Our Swiss representative office, TRB CHEMEDICA SA, is located in Vouvry, Valais. Here, two production units and a research and development department work in close collaboration. In fact, it is here that the entire OSTENIL® product range is produced.

TRB CHEMEDICA SA's offering on the Swiss market includes ophthalmology with VISMED® - hyaluronic acid-based eye drops. Thanks to their unique composition, these have set a new standard and become the therapy of choice for dry eyes. In orthopedics, TRB CHEMEDICA SA has set new standards with the OSTENIL® product range - injections for the treatment of degenerative and traumatic joint alterations such as osteoarthritis. In Switzerland, Ostenil products were the first products containing biofermented hylaluronic acid to be approved for intra-articular use in all synovial joints. The OSTENIL® brand has been recognized for 20 years for its high efficacy and good tolerance.